Latham & Watkins Advised Omada Health on its Initial Public Offering

Latham & Watkins Advised Omada Health on its Initial Public Offering

Latham & Watkins LLP advised Omada Health, a virtual between-visit healthcare provider, on its initial public offering of 7,900,000 shares of common stock at a public offering price of US$19.00 per share. The underwriters have also been granted a 30-day option to purchase up to 1,185,000 additional shares at the IPO price, less underwriting discounts and commissions.

The shares are expected to begin trading on the Nasdaq Global Select Market on June 6, 2025, under the ticker symbol “OMDA”. The offering is expected to close on June 9, 2025, subject to customary closing conditions.

The Latham & Watkins team was led by Kathleen Wells (Partner, Bay Area) and Richard Kim (Partner, Bay Area), with support from associates Josh Landis, Jacob Kempf, Ryleigh Chen, and Keran Huang. Regulatory advice was provided by Ben Haas (Partner, Washington, D.C.) and Betty Pang (Partner, Bay Area), with associate Meryl Bartlett. On benefits matters, the team included Ashley Wagner (Partner, Bay Area) and Sandhya Chandrasekhar (Counsel, Chicago), with associate Megan Ampe. Data privacy advice was provided by Heather Deixler (Partner, Bay Area). Intellectual property matters were handled by Arielle Singh (Counsel, Bay Area), with associate Caroline Omotayo. Tax matters were advised on by Grace Lee (Partner, Bay Area), with associate Rasha Suleiman.

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.